OtherCommentary
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and other Drug Device Combination Products
Cheryl L.M. Stults, Christine L. Lanning, Lee M. Nagao and James Conners
PDA Journal of Pharmaceutical Science and Technology November 2023, pdajpst.2023.012852; DOI: https://doi.org/10.5731/pdajpst.2023.012852
Cheryl L.M. Stults
1 C & M Technical Consulting, LLC;
Christine L. Lanning
2 Merck & Co., Inc.;
Lee M. Nagao
3 Faegre Drinker Biddle & Reath LLP;
James Conners
4 Sunovion
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 1
January/February 2025
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and other Drug Device Combination Products
Cheryl L.M. Stults, Christine L. Lanning, Lee M. Nagao, James Conners
PDA Journal of Pharmaceutical Science and Technology Nov 2023, pdajpst.2023.012852; DOI: 10.5731/pdajpst.2023.012852
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and other Drug Device Combination Products
Cheryl L.M. Stults, Christine L. Lanning, Lee M. Nagao, James Conners
PDA Journal of Pharmaceutical Science and Technology Nov 2023, pdajpst.2023.012852; DOI: 10.5731/pdajpst.2023.012852
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.